Notice of Special Interest: Promoting Research Opportunities on HIV/AIDS in NIAMS
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-23-004.html
november 21, 2022pa-20-185: nih research project grant (parent r01 clinical trial not allowed)pa-20-195: nih exploratory/developmental research grant program (parent r21 clinical trial not allowed)pa-20-272: administrative supplements to existing nih grants and cooperative agreements (parent admin supp clinical trial optional)par-23-025: ancillary studies to ongoing clinical projects (r01 clinical trial not allowed)par-23-026: ancillary studies to ongoing clinical projects (r21 clinical trial not allowed)par-21-053: clinical observational (co) studies in musculoskeletal, rheumatic, and skin diseases (r01 clinical trial not allowed)national institute of arthritis and musculoskeletal and skin diseases (niams)the purpose of this announcement is to inform potential applicants to the national institute of arthritis and musculoskeletal and skin diseases (niams) of an area of special interest in hiv/aids-associated comorbidities that are within the niams mission.background the hiv/aids pandemic has been a challenging us public health issue. the nih has provided the largest public investment in hiv/aids research globally. in line with overall nih efforts, niams would like to promote observational, translational, and basic/pre-clinical research focusing on how the presence or treatment of hiv/aids impacts systemic rheumatic, musculoskeletal and skin disease progression and pathogenesis with a focus on utilization of existing hiv cohorts and repositories.research objectives applications should meet the nih hiv/aids research priorities and guidelines: https://grants.nih.gov/grants/guide/notice-files/not-od-20-018.html. niams is interested in supporting studies focused on, but not limited to:examples of hiv/aids-associated comorbidities that are within the niams mission are:application and submission informationthis notice applies to due dates on or after february 5, 2023 and subsequent receipt dates through january 8, 2028.submit applications for this initiative using one of the following funding opportunity announcements (foas) or any reissues of these announcement through the expiration date of this notice.par-21-053: clinical observational (co) studies in musculoskeletal, rheumatic, and skin diseases (r01 clinical trial not allowed)all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:applications nonresponsive to terms of this nosi will not be considered for the nosi initiative.scientific/research contact(s)heiyoung park, ph.d. national institute of arthritis and musculoskeletal and skin diseases (niams) telephone: 301-594-5032 email: parkh1@mail.nih.govfinancial/grants management contact(s)erik edgerton national institute of arthritis and musculoskeletal and skin diseases (niams) telephone: 301-594-7760 email: edgertont@mail.nih.govweekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.